120 related articles for article (PubMed ID: 23073805)
1. Experimental study on dynamic regulation of acetylcholine in striatum of rat Parkinson disease model and behavior observation.
Cao F; Luo F; Chen L; Chen H; Wei G; Cai J; Xu H; Tong E
J Huazhong Univ Sci Technolog Med Sci; 2012 Oct; 32(5):732-736. PubMed ID: 23073805
[TBL] [Abstract][Full Text] [Related]
2. Effects of eldepryl on glial cell proliferation and activation in the substantia nigra and striatum in a rat model of Parkinson's disease.
Liu B; Lv C; Zhang J; Liu Y; Sun J; Cheng X; Mao W; Ma Y; Li S
Neurol Res; 2017 May; 39(5):459-467. PubMed ID: 28276259
[TBL] [Abstract][Full Text] [Related]
3. [Effect of electroacupuncture on morphological changes and apoptosis of substantia nigra cells in Parkinson's disease rats].
Wang YC; Cheng YH; Ma J; Gan SY; Wang SJ; Zhou H; Du YJ; Yang M; Shen F
Zhen Ci Yan Jiu; 2010 Dec; 35(6):415-21. PubMed ID: 21375014
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of α-lipoic acid promoting iron efflux in substantia nigra cells of Parkinson's disease rats].
Cai T; Wei C; Zhai S; Tai S; Zhang C; Jiao L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):35-40. PubMed ID: 29595455
[TBL] [Abstract][Full Text] [Related]
5. [Effects of electroacupuncture on behaviors and dopaminergic neurons in the rat of Parkinson's disease].
Ma J; Wang YC; Gan SY
Zhongguo Zhen Jiu; 2006 Sep; 26(9):655-7. PubMed ID: 17036487
[TBL] [Abstract][Full Text] [Related]
6. Is nicotine protective against Parkinson's disease? An experimental analysis.
García-Montes JR; Boronat-García A; López-Colomé AM; Bargas J; Guerra-Crespo M; Drucker-Colín R
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):897-906. PubMed ID: 23131151
[TBL] [Abstract][Full Text] [Related]
7. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
8. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
Li J; Wang LN; Xiao HL; Li X; Yang JJ
Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glutamate and acetylcholine release in behavioral improvement induced by electroacupuncture in parkinsonian rats.
Sun Z; Jia J; Gong X; Jia Y; Deng J; Wang X; Wang X
Neurosci Lett; 2012 Jun; 520(1):32-7. PubMed ID: 22583765
[TBL] [Abstract][Full Text] [Related]
10. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Shuanggu Yitong needling method on proliferation and differentiation of nerve stem cells in the Parkinson's disease model rat].
Wang YC; Ma J; Wang H
Zhongguo Zhen Jiu; 2006 Apr; 26(4):277-82. PubMed ID: 16642616
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal damage and white matter lesions contribute to cognitive impairment in MPTP-lesioned mice with chronic cerebral hypoperfusion.
Gao Y; Tang H; Nie K; Zhu R; Gao L; Feng S; Wang L; Zhao J; Huang Z; Zhang Y; Wang L
Behav Brain Res; 2019 Aug; 368():111885. PubMed ID: 30959125
[TBL] [Abstract][Full Text] [Related]
13. Assessment of vitamin D and inflammatory markers profile in cardiac tissue on Parkinson disease animal model.
Nejm MB; Guimarães-Marques MJ; Oliveira LF; Damasceno L; Andersen ML; Tufik S; Fonseca F; Olszewer E; Leça R; de Almeida ACG; Scorza FA; Scorza CA
Pharmacol Rep; 2020 Apr; 72(2):296-304. PubMed ID: 32124387
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat.
Olds ME; Jacques DB; Kopyov O
Synapse; 2005 Jan; 55(1):26-36. PubMed ID: 15499610
[TBL] [Abstract][Full Text] [Related]
15. Selective A
Fathalla AM; Soliman AM; Moustafa AA
Neurosci Lett; 2017 Mar; 643():89-96. PubMed ID: 28213070
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation in expression of vesicular glutamate transporter 3 in substantia nigra but not in striatum of 6-hydroxydopamine-lesioned rats.
Chung EK; Chen LW; Chan YS; Yung KK
Neurosignals; 2006-2007; 15(5):238-48. PubMed ID: 17435391
[TBL] [Abstract][Full Text] [Related]
17. Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease.
Yin LH; Shen H; Diaz-Ruiz O; Bäckman CM; Bae E; Yu SJ; Wang Y
BMC Neurosci; 2012 Oct; 13():120. PubMed ID: 23040108
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
[TBL] [Abstract][Full Text] [Related]
19. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
Wang X; Yang HA; Wang XN; Du YF
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]